Royal Bank of Canada Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $15.00
Wave Life Sciences (NASDAQ:WVE – Get Free Report) had its price target boosted by research analysts at Royal Bank of Canada from $7.00 to $15.00 in a report issued on Monday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price suggests a potential downside of […]
More Stories
Pluri Inc. (NASDAQ:PLUR) Short Interest Up 125.7% in December
Pluri Inc. (NASDAQ:PLUR – Get Free Report) saw a large growth in short interest in the month of December. As...
Global X PropTech ETF (NASDAQ:PTEC) Short Interest Update
Global X PropTech ETF (NASDAQ:PTEC – Get Free Report) was the target of a large decline in short interest in...
Insider Buying: Happy Creek Minerals Ltd. (CVE:HPY) Insider Buys 263,000 Shares of Stock
Happy Creek Minerals Ltd. (CVE:HPY – Get Free Report) insider Patrick Triggs purchased 263,000 shares of the stock in a...
Isuzu Motors Limited (OTCMKTS:ISUZY) Short Interest Up 130.6% in December
Isuzu Motors Limited (OTCMKTS:ISUZY – Get Free Report) was the recipient of a significant growth in short interest in the...
Huntington Bancshares Incorporated (NASDAQ:HBANM) Sees Significant Increase in Short Interest
Huntington Bancshares Incorporated (NASDAQ:HBANM – Get Free Report) saw a large growth in short interest during the month of December....
Kura Oncology Signs Lease Agreement for New Executive Offices
Kura Oncology, Inc. (NASDAQ:KURA) recently announced on January 13, 2025, that the company has entered into a lease agreement with...